retatrutide glp1 for weight loss: Study shows 30% body weight loss Retatrutide 40mg Pen | Triple

In the meta-analysis of 3 studies 20,28,32 which compared a GLP-1-based therapy against a comparator, GLP-1-based therapies were found to increase % FMD non-significantly (mean difference [95% CI] in the changes from baseline: 1.65 [0.89, 4.18] %

& Asarian, L

At week 26, treatment with liraglutide injection was superior in reducing HbA1c from baseline versus placebo

However, it distinguishes itself by acting on two additional hormones: glucose-dependent insulinotropic polypeptide (GIP), which aids in blood sugar management, and glucagon, which can help suppress appetite and increase energy expenditure

No clinical trial has tested the retatrutide+cagrilintide combination as of May 2026

Medical Review: A US-licensed physician reviews your profile and prescribes your starting dose